This web-based activity is designed to help you assess and enhance your current practices in documenting seizure frequency, type, and time since last seizure for patients with epilepsy in a clinical setting. The primary goal of this performance improvement project is to establish or refine a standardized process for capturing and documenting key seizure activity parameters—seizure type, seizure frequency, and time since last seizure—for all patients with a primary diagnosis of epilepsy.
Please be aware this activity will take at least 32 days to complete. After completing all learning material in Stage B, the learner should implement the learned interventions into practice over the next 30 days. After 30 days, the learner will have access to Stage C, which will measure the success of the interventions.The activity consists of three stages:
For additional details on activity objectives, rationale, process, and example metrics, refer to the slide set: Performance Improvement Project: Seizure Frequency Process and Outcome
Deepti Zutshi, MD
Alexandria Melendez-Zaidi, MD
Jorge Marcos, MD
Jonathan Williams, MD
Brandy Fureman, PhD
Resolution of Conflicts of Interest
It is the policy of the American Epilepsy Society (AES) to ensure balance, independence, objectivity and scientific rigor. All individuals involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. Conflicts of interest will be resolved by AES prior to an educational activity being delivered to learners.
Unapproved Use Disclosure
The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity.
Contact Information
For further information on this activity contact the American Epilepsy Society at education@aesnet.org or call 312.883.3800.
Privacy and Confidentiality
The American Epilepsy Society respects the privacy and confidentiality of users of this CME activity. You may access the privacy statement for this activity here.
Policy on Commercial Support and Conflict of Interest
As an ACCME-accredited provider the American Epilepsy Society must ensure 100% compliance with the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities. The American Epilepsy Society has implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.
Disclosure of Unlabeled/Unapproved Uses
This educational activity may include references to the use of products for indications not approved by the FDA. Faculty have agreed to disclose intent to discuss any off-label, experimental, or investigational use of drugs, devices, or equipment or devices in their presentations.  Furthermore, faculty have attested that all the recommendations involving clinical medicine they make in this activity will be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; and, all scientific research referred to, reported, or used in their presentation in support or justification of a patient care recommendation will conform to the generally accepted standards of experimental design, data collection and analysis.  Faculty opinions expressed with regard to unapproved, investigational or experimental uses of products are solely those of the faculty and are not endorsed by the American Epilepsy Society.
Disclaimer
This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational and/or experimental uses.